Lv Tongrui

Lv Tongrui is a Full-time Distinguished Researcher and Director at the Institute of Biological Chemistry, Academia Sinica. His work bridges synthetic chemistry and biochemical analysis to develop therapeutic agents targeting carbohydrate-processing enzymes, particularly in the context of tuberculosis.

• Ph.D. in Chemistry (University of Alberta, 1993)
• Director, Institute of Biological Chemistry, Academia Sinica (2019–present)
• RU Lemieux Chair in Carbohydrate Chemistry (2015–2021)

Research focuses on carbohydrate chemistry, oligosaccharide conformational analysis, and inhibitor development for tuberculosis. Key areas include total synthesis of mycobacterial cell wall components, characterization of glycosyltransferases, and vaccine development using synthetic glycans.

Recent publications highlight advances in oligosaccharide synthesis (2022), TB vaccine antigens (2021), and glycan-based diagnostics (2019). Scientific awards include the RU Lemieux Chair and Canada Research Chair in carbohydrate chemistry.